These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 11817993

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C.
    Arthritis Rheum; 2002 Dec 15; 47(6):655-61. PubMed ID: 12522841
    [Abstract] [Full Text] [Related]

  • 3. [Contribution of leflunomide to the cost effectiveness of sequential DMARD therapy of rheumatoid arthritis in Germany].
    Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.
    Z Rheumatol; 2004 Feb 15; 63(1):59-75. PubMed ID: 14991279
    [Abstract] [Full Text] [Related]

  • 4. Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
    Ollendorf DA, Peterson AN, Doyle J, Huse DM.
    Am J Manag Care; 2002 May 15; 8(7 Suppl):S203-13. PubMed ID: 12022236
    [Abstract] [Full Text] [Related]

  • 5. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany: I. Selected DMARDs and patient-related costs.
    Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.
    Pharmacoeconomics; 2005 May 15; 23(4):377-93. PubMed ID: 15853437
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.
    Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM.
    Ann Intern Med; 2002 Nov 05; 137(9):726-33. PubMed ID: 12416946
    [Abstract] [Full Text] [Related]

  • 8. Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency.
    Schädlich PK, Zeidler H, Zink A, Gromnica-Ihle E, Schneider M, Straub C, Brecht JG, Huppertz E.
    Pharmacoeconomics; 2005 Nov 05; 23(4):395-420. PubMed ID: 15853438
    [Abstract] [Full Text] [Related]

  • 9. Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
    Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A.
    Arthritis Rheum; 2000 Mar 05; 43(3):506-14. PubMed ID: 10728742
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications.
    Hewitson PJ, Debroe S, McBride A, Milne R.
    J Clin Pharm Ther; 2000 Aug 05; 25(4):295-302. PubMed ID: 10971781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients.
    Ishaq M, Muhammad JS, Hameed K, Mirza AI.
    Mod Rheumatol; 2011 Aug 05; 21(4):375-80. PubMed ID: 21229373
    [Abstract] [Full Text] [Related]

  • 20. Leflunomide: a review of its use in active rheumatoid arthritis.
    Prakash A, Jarvis B.
    Drugs; 1999 Dec 05; 58(6):1137-64. PubMed ID: 10651393
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.